Uk Mhra Gmp
ALMAC CLINICAL SERVICES LIMITEDALMAC CLINICAL SERVICES LIMITED – UK MHRA GMP Certificate UK MIA(IMP) 20377 Insp GMP/GDP/IMP 20377/13423-0032[I]
Record Details
This Uk Mhra Gmp record concerns ALMAC CLINICAL SERVICES LIMITED, with an inspection on January 20, 2026, issued by the MHRA, covering drugs.
- Compliance status
- GMPC
- Certificate type
- GMP/GDP
- Inspection date
- January 20, 2026
- Issued
- April 2, 2026
- MIA number
- UK MIA(IMP) 20377
- Site address
- ALMAC CLINICAL SERVICES LIMITED, SEAGOE INDUSTRIAL ESTATE, 9 CHARLESTOWN ROAD, CRAIGAVON, BT63 5PW, UNITED KINGDOM
- Country
- UNITED KINGDOM
- Products
- Human Investigational Medicinal Products
- Manufacturing operations
- 1. MANUFACTURING OPERATIONS [ 1.1 ] Sterile Investigational Medicinal Products [ 1.1.3 ] Batch certification [ 1.2 ] Non-sterile investigational medicinal products [ 1.2.1 ] Non-Sterile Products (processing operations for the following dosage forms) [ 1.2.1.1 ] Capsules, hard shell [ 1.2.1.8 ] Other solid dosage forms [ 1.2.1.17 ] Other non-sterile medicinal productsOther solid dosage forms - Placebo Powders blistered for inhalers. Capsules, hard shell includes penicillins, hormones and cytotoxics/Capsules soft shell [ 1.2.2 ] Batch certification [ 1.3 ] Biological investigational medicinal products [ 1.3.2 ] Batch certification [ 1.3.2.1 ] Blood products [ 1.3.2.2 ] Immunological products [ 1.3.2.3 ] Cell therapy products [ 1.3.2.4 ] Gene therapy products [ 1.3.2.5 ] Biotechnology products [ 1.3.2.6 ] Human or animal extracted products [ 1.4 ] Other products or manufacturing activity [ 1.4.1 ] Manufacture of: [ 1.4.1.1 ] Herbal products [ 1.4.1.2 ] Homeopathic products [ 1.4.1.3 ] OtherImportation of QP certified IMPs from a country on the approved country for import list / Herbal products, Homeopathic products, Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc) None [ 1.5 ] Packaging [ 1.5.1 ] Primary packaging [ 1.5.1.1 ] Capsules, hard shell [ 1.5.1.2 ] Capsules, soft shell [ 1.5.1.8 ] Other solid dosage forms [ 1.5.1.12 ] Suppositories [ 1.5.1.13 ] Tablets [ 1.5.1.17 ] Other non-sterile medicinal productsPlacebo powders blistered for inhalers/Capsules, hard shell,Capsules, soft shell and tablets includes penicillins, hormones and cytotoxics [ 1.5.2 ] Secondary packaging [ 1.6 ] Quality control testing [ 1.6.3 ] Chemical/Physical 2. IMPORTATION OF MEDICINAL PRODUCTS [ 2.1 ] Quality control testing of imported medicinal products [ 2.1.3 ] Chemical/Physical [ 2.2 ] Batch certification of imported medicinal products [ 2.2.1 ] Sterile Products [ 2.2.1.1 ] Aseptically prepared [ 2.2.1.2 ] Terminally sterilised [ 2.2.2 ] Non-sterile products [ 2.2.3 ] Biological medicinal products [ 2.2.3.1 ] Blood products [ 2.2.3.2 ] Immunological products [ 2.2.3.3 ] Cell therapy products [ 2.2.3.4 ] Gene therapy products [ 2.2.3.5 ] Biotechnology products [ 2.2.3.6 ] Human or animal extracted products [ 2.3 ] Other Importation Activities [ 2.3.1 ] Site of Physical Importation [ 2.3.2 ] Importation of Intermediate which undergoes further processing [ 2.3.4 ] OtherImportation of QP certified IMPs from a country on the approved country for import list / Herbal products, Homeopathic products, Products authorised under regulation 174 (supply in response to spread of pathogenic agents etc)
View Company Profile
ID · 95f1d2f3-fd61-477a-b4e0-ebda000d87e4
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.